NCT03708211: A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors |
|
|
| Completed | 1 | 20 | Europe | TAK-931 PIC, TAK-931 Tablet, Esomeprazole | Millennium Pharmaceuticals, Inc. | Neoplasms, Advanced Solid | 12/19 | 12/19 | | |
NCT02699749: A Study to Evaluate TAK-931 in Participants With Advanced Nonhematologic Tumors |
|
|
| Completed | 1 | 80 | Japan | TAK-931 | Millennium Pharmaceuticals, Inc. | Nonhematologic Neoplasms, Advanced | 12/19 | 12/19 | | |